SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019027
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:34
Documents
110
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gdnsf-20230930x10q.htm   iXBRL 10-Q 1840914
2 EX-10.47 gdnsf-20230930xex10d47.htm EX-10.47 49698
3 EX-10.48 gdnsf-20230930xex10d48.htm EX-10.48 46435
4 EX-10.49 gdnsf-20230930xex10d49.htm EX-10.49 81790
5 EX-31.1 gdnsf-20230930xex31d1.htm EX-31.1 15608
6 EX-32.1 gdnsf-20230930xex32d1.htm EX-32.1 8849
  Complete submission text file 0001558370-23-019027.txt   9405402

Data Files

Seq Description Document Type Size
7 EX-101.SCH gdnsf-20230930.xsd EX-101.SCH 82063
8 EX-101.CAL gdnsf-20230930_cal.xml EX-101.CAL 86081
9 EX-101.DEF gdnsf-20230930_def.xml EX-101.DEF 288728
10 EX-101.LAB gdnsf-20230930_lab.xml EX-101.LAB 622134
11 EX-101.PRE gdnsf-20230930_pre.xml EX-101.PRE 508997
104 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20230930x10q_htm.xml XML 1658963
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56225 | Film No.: 231406452
SIC: 2834 Pharmaceutical Preparations